Drug intelligence / Profile preview

NER1008

Development stage
Unknown
Lead developer
Norgine
Modality
Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Rectal
01

Overview

NER1008 is a rectal enema formulation containing polyethylene glycol 3350 (PEG3350), developed by Norgine for bowel cleansing prior to flexible sigmoidoscopy. It functions as an osmotic laxative, where the PEG3350 polymer retains water within the rectum and sigmoid colon. This increases the volume of the stool, leading to rectal distension and triggering the natural urge to evacuate, thereby clearing the distal colon of solid matter. This preparation is intended to provide a clear view for endoscopic procedures without the need for extensive dietary restrictions or oral bowel preparations. While it contains a pharmaceutical active ingredient, it is classified as a medical device in some clinical contexts.

Other names
PEG3350 enemaPEG-3350 enemaPEG 3350 enemapolyethylene glycol 3350 enema

Beyond the preview

Go deeper on NER1008.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NER1008.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call